Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
THK, a global leader in manufacturing, is seeking startups to solve several manufacturing challenges to improve quality, cost and throughput of our products.
Investing in the Drivers of the Future of Energy, Ben Sampson, Director, Energy, GE Ventures
Christina Qi, Partner, Domeyard LP
Dilip Sundaram - Corporate Keynote
Matthew Osman, Legit
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals